Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment.
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab.
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
Group Behavior and Emergence of Cancer Drug Resistance.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Group Behavior and Emergence of Cancer Drug Resistance.
Group Behavior and Emergence of Cancer Drug Resistance. Trends Cancer. 2021 04; 7(4):323-334.
View in:
PubMed
subject areas
Animals
Drug Resistance, Neoplasm
Genetic Heterogeneity
Humans
Neoplasms
Phenotype
Tumor Microenvironment
authors with profiles
Ravi Salgia